These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2387642)

  • 1. Luteinizing hormone pulsatility in men with damage to the germinal epithelium.
    Talbot JA; Shalet SM; Tsatsoulis A; Grabinski M; Robertson WR
    Int J Androl; 1990 Jun; 13(3):223-31. PubMed ID: 2387642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium.
    Tsatsoulis A; Whitehead E; St John J; Shalet SM; Robertson WR
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):683-9. PubMed ID: 3138051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency.
    Howell SJ; Radford JA; Ryder WD; Shalet SM
    J Clin Oncol; 1999 May; 17(5):1493-8. PubMed ID: 10334536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pulsatile secretion of bioactive luteinising hormone in normal adult men.
    Talbot JA; Rodger RS; Shalet SM; Littley MD; Robertson WR
    Acta Endocrinol (Copenh); 1990 May; 122(5):643-50. PubMed ID: 2112817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis.
    Tsatsoulis A; Shalet SM; Morris ID; de Kretser DM
    Horm Res; 1990; 34(5-6):254-9. PubMed ID: 2129227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone.
    Veldhuis JD; King JC; Urban RJ; Rogol AD; Evans WS; Kolp LA; Johnson ML
    J Clin Endocrinol Metab; 1987 Nov; 65(5):929-41. PubMed ID: 3117834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma inhibin levels in men with chemotherapy-induced severe damage to the seminiferous epithelium.
    Tsatsoulis A; Shalet SM; Robertson WR; Morris ID; Burger HG; De Kretser DM
    Clin Endocrinol (Oxf); 1988 Dec; 29(6):659-65. PubMed ID: 3151478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile bioactive luteinizing hormone secretion in men with chronic renal failure and following renal transplantation.
    Talbot JA; Rodger RS; Robertson WR
    Nephron; 1990; 56(1):66-72. PubMed ID: 2122267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    Clark ST; Radford JA; Crowther D; Swindell R; Shalet SM
    J Clin Oncol; 1995 Jan; 13(1):134-9. PubMed ID: 7799013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone and follicle stimulating hormone secretion patterns in boys throughout puberty measured using highly sensitive immunoradiometric assays.
    Wennink JM; Delemarre-van de Waal HA; Schoemaker R; Schoemaker H; Schoemaker J
    Clin Endocrinol (Oxf); 1989 Nov; 31(5):551-64. PubMed ID: 2516786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis.
    Mulligan T; Iranmanesh A; Kerzner R; Demers LW; Veldhuis JD
    Eur J Endocrinol; 1999 Sep; 141(3):257-66. PubMed ID: 10474123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
    van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
    Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
    An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
    Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
    Veldhuis JD; Rogol AD; Johnson ML
    J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular function following the treatment of Hodgkin's disease in childhood.
    Shafford EA; Kingston JE; Malpas JS; Plowman PN; Pritchard J; Savage MO; Eden OB
    Br J Cancer; 1993 Dec; 68(6):1199-204. PubMed ID: 8260374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal function following chemotherapy for childhood Hodgkin's disease.
    Mackie EJ; Radford M; Shalet SM
    Med Pediatr Oncol; 1996 Aug; 27(2):74-8. PubMed ID: 8649323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.
    Gross KM; Matsumoto AM; Southworth MB; Bremner WJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
    van den Berg H; Furstner F; van den Bos C; Behrendt H
    Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.